Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00097253 · ClinicalTrials.gov registry record · Phase 1
The Effects of Smell on Mood and Physical Responses
A Phase 1 study of Depression and Anxiety, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 1
- Development phase
- 56
- Enrollment target
- 1
- Study location
NCT00097253: Completed Phase 1 study of Depression and Anxiety, sponsored by National Center for Complementary and Integrative Health (NCCIH).
NCT00097253 is a Phase 1 study of Depression and Anxiety that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 56 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00097253, a Phase 1 study of Depression and Anxiety, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 56 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine the body's response to relaxing and stimulating fragrances commonly used in aromatherapy.
Primary Outcome
Cortisol, norepinephrine, epinephrine measured before and after physical (cold pressor) stressor, which occurred at 11:00.
Conditions Studied
Interventions
- BEHAVIORAL Exposure to relaxant and stimulant odors
Study Locations (1)
Ohio
- Ohio State University Institute for Biobehavioral Medicine Research - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2005-08 |
| Est. Completion | 2006-03 |
| Phase | Phase 1 |
What the finished NCT00097253 record still lists
NCT00097253 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (93% lower).
The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Exposure to relaxant and stimulant odors is the first listed.
NCT00097253 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT00097253 about?
NCT00097253 is a clinical study titled "The Effects of Smell on Mood and Physical Responses". The purpose of this study is to examine the body's response to relaxing and stimulating fragrances commonly used in aromatherapy.
What is the current status of trial NCT00097253?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 56 participants. The study started on 2005-08. Estimated completion is 2006-03.
What conditions does trial NCT00097253 study?
This clinical trial studies the following conditions: Depression, Anxiety, Stress.
What interventions are being tested in trial NCT00097253?
The interventions under investigation include: Exposure to relaxant and stimulant odors (BEHAVIORAL).
Who is sponsoring clinical trial NCT00097253?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00097253 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00097253's enrollment target sits among peer trials
56 454th of 679 higher than 225 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
RECRUITING · Phase 1
-
PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)
RECRUITING · Phase 1
-
Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression
RECRUITING · Phase 1
-
Study of the Safety, Tolerability, Electrophysiological Effects and Efficacy of DMT in Humans
RECRUITING · Phase 1
-
[18F]PF-06445974 to Image PDE4B in Major Depressive Disorder Using PET
RECRUITING · Phase 1
-
Feasibility and Safety of Ketamine for Suicidal Patients in the Emergency Department
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia